Transplant Tolerance Induction in Newborn Infants: Mechanisms, Advantages, and Potential Strategies

Area of Science:

• Immunology
• Transplantation Science
• Pediatric Medicine

Background:

• Established tolerance induction protocols exist for adult renal transplantation, but not for infants.
• Pediatric transplant recipients face significant risks from long-term immunosuppression and chronic rejection.
• Infants' immunological immaturity and thymic function present unique opportunities for central tolerance induction.

Purpose of the Study:

• To review mechanisms and strategies for transplant tolerance induction in immunologically immature infant recipients.
• To analyze neonatal tolerance in murine models and its application to human infants.
• To discuss advances in adult tolerance induction and their potential relevance to pediatric transplantation.

Main Methods:

• Review of murine experimental models of neonatal tolerance.
• Analysis of human newborn infant tolerance induction studies.
• Discussion of hematopoietic stem cell transplantation, cell-based therapies, costimulatory blockade, and thymus manipulation.

Main Results:

• Neonatal tolerance mechanisms in mice provide a foundation for understanding infant tolerance.
• In utero hematopoietic stem cell transplantation studies inform hematopoietic mixed chimerism in neonates.
• Recent adult tolerance induction strategies offer potential avenues for pediatric applications.

Conclusions:

• Establishing transplant tolerance induction in infants is a promising area requiring further research.
• Future studies should focus on patient selection, less toxic conditioning, and biomarkers for immunosuppression management.
• Successful infant tolerance induction could significantly reduce long-term risks associated with pediatric solid organ transplantation.